GlobeNewswire Inc | Aug 9, 2021 04:05PM EDT

August 09, 2021

MOUNTAIN VIEW, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX),a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company plans to participate in the upcoming H.C. Wainwright Ophthalmology Virtual Conference.

David Bruce, Iridexs President and Chief Executive Officer, is scheduled to present on Tuesday, August 17, 2021, at 7:00 am ET. Interested parties may access a live and archived webcast of the presentation at http://www.iridex.com.

About IRIDEXIridexis a worldwide leader in developing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Companys proprietaryMicroPulsetechnology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions.Iridexs current product line is used for the treatment of glaucoma, diabetic macular edema and other retinal diseases.Iridexproducts are sold intheUnited StatesandGermanythrough a direct sales force and in more than 100 countries through a network of independent distributors. For more information, visitwww.iridex.com.

Investor Relations ContactLeigh Salvo(415) 937-5404investors@iridex.com